Table 2 Relationship between FPR1 expression and clinicopathological features of ovarian cancer tissues
FPR1 staining (%) | FPR1 staining (intensity) | |||||||
|---|---|---|---|---|---|---|---|---|
Neg ≤ 10 | Pos ≥ 80 | P-valuea | 0 | 1 | 2 | |||
EOC tissues | n.cases | 37 (100.0) | 11 (29.7) | 26 (70.3) | 0.391 | 11 (29.7) | 17 (45.9) | 9 (24.3) |
Age | ≤50 | 8 (21.6) | 1 (2.7) | 7 (18.9) | 0.08 | 1 (2.7) | 3 (10.8) | 4 (10.8) |
> 50 | 29 (78.4) | 10 (27.0) | 19 (51.4) | 0.11 | 10 (27.0) | 14 (37.8) | 5 (13.5) | |
Histotype | LGSC | 3 (8.1) | 1 (2.7) | 2 (5.4) | 0.612 | 1 (2.7) | 2 (5.4) | 0 (0.0) |
HGSC | 28 (75.7) | 8 (21.6) | 20 (54.1) | 8 (21.6) | 13 (35.1) | 7 (18.9) | ||
OCCC | 5 (13.5) | 1 (2.7) | 4 (10.8) | 1 (2.7) | 2 (5.4) | 2 (5.4) | ||
mEOC | 1 (2.7) | 1 (2.7) | 0 (0.0) | 1 (2.7) | 0 (0.0) | 0 (0.0) | ||
FIGO | I | 6 (16.2) | 3 (8.1) | 3 (8.1) | 0.42 | 3 (8.1) | 2 (5.4) | 1 (2.7) |
II | 9 (24.3) | 1 (2.7) | 8 (21.6) | 1 (2.7) | 4 (10.8) | 4 (10.8) | ||
III | 21 (56.8) | 7 (18.9) | 14 (37.8) | 7 (18.9) | 10 (27.0) | 4 (10.8) | ||
IV | 1 (2.7) | 0 (0.0) | 1 (2.7) | 0 (0.0) | 1 (2.7) | 0 (0.0) | ||